Oncolytics Biotech Inc T.ONC

Target lowered to 5$ from 15$ at HC Wainwright

[askretka]

Oncolytics price target lowered to $5 from $15 at H.C. Wainwright

H.C. Wainwright lowered the firm's price target on Oncolytics to $5 from $15 and keeps a Buy rating on the shares. The analyst says pelareorep demonstrated encouraging efficacy in anal cancer, while the company's clinical development path in pancreatic cancer shifts. The target drop reflects an increase in estimated expenses related to pela's clinical development and a potential launch in 2027, the analyst tells investors in a research note.

Got this summary from Thefly.com 
You can get more info by clicking on the link if you create a free account and sign in.

I find it quite useful at times for getting info on my investments. Cheers!!!!!!!!!!!!!!!!!!!!!





 

[13X2413]

Well, these last two posts certainly ruined my chance at having a nice sleep. The negativity just keeps building. The Anson deal opens up a lot of discussion on ONC's decision making and a downgrade based on a 2027 timeframe really sucks! 2027!? The recently mentioned late 2024 timeframe was bad enough. 

[Azzak34]

It's great how you idiots ridicule the analysts when they set a price of $15 then put so much weight to their price target reduction. They're all saying buy, they're all saying the target is higher from here, at least double in fact.